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A b s t r a c t
Measurement o f  estradiol is useful in assisted  
reproduction, evaluation o f  infertility, menopause, and 
male feminization. The analytic performance o f  8  
estradiol immunoassays was evaluated. The 
imprecision and accuracy o f  the Access, AD VIA  
Centaur, A R C H IT E C T  i2000 , AutoDELFIA, Elecsys 
2010, IM M U LIT E  2000, and Vitros E C i estradiol 
assays (see text fo r  proprietary information) were 
evaluated by using an isotope dilution—gas 
chromatography-mass spectrometry (ID -G C -M S ) 
reference method.
The coefficient o f  variation (CV) ranged from  6 .9 %  
on the Elecsys 2 0 1 0  lo 4 2 .6 %  on the A D V IA  Centaur at 
an estradiol concentration o f  1 8  pg/m L (66  pmol/L), 
with the A R C H IT E C T  12000 assay in development and 
the Vitros E C i having a C V  below 1 0 %  at this estradiol 
concentration. Agreement between the automated 
assays and ID -G C -M S  was variable, with slopes 
ranging from  0 .8 7  to 1.20. The Access, A R C H IT E C T  
12000 in development, and the IM M U LIT E  2 0 0 0  were 
the most accurate, with slopes o f 0.99, 0.98, and 1.03, 
respectively. These findings indicate that the 
A R C H IT E C T  12000 estradiol assay in development had 
the best precision and accuracy o f  the assays evaluated 
fo r  measurement o f  serum estradiol concentrations.
Estradiol, a steroid hormone, is the most potent of the 
naturally occurring estrogens, and in the nonpregnant 
female, it is derived almost exclusively from the ovaries. 
Estradiol is responsible for the development and mainte­
nance of the female sex organs and secondary sex charac­
teristics. It also has important roles in regulation of the 
menstrual cycle and in maintenance of pregnancy. Estradiol 
measurements frequently are used during evaluation of 
female infertility and menopause and feminization in males 
and in assisted reproduction to monitor follicular develop­
ment.1 Physiologic levels are low, often less than 50 pg/mL 
(184 pm ol/L), in men, children, and postmenopausal 
women and can range widely, from 5 to 410 pg/mL (18­
1,505 pmol/L), in menstruating women.2 The wide refer­
ence intervals and the clinical applications o f this assay 
dictate the need for high sensitivity, excellent accuracy and 
precision through a wide analytical range, and a prompt 
turnaround time. Concern regarding these requirements, 
accuracy in particular, led to efforts toward standardization 
o f serum estradiol measurements through a reference 
serum panel with estradiol concentrations determined by 
isotope dilution-gas chromatography-mass spectrometry 
(ID-GC-MS).3-4
Recently, estradiol assays have become available on a 
number of fully automated immunoassay analyzers. While 
these systems provide rapid turnaround times and high 
throughput, there presently are only limited reports regarding 
the analytic performance of these assays, and most do not 
assess accuracy with ID-GC-MS as the reference method.5"8 
The aim of our study was to assess the imprecision and accu­
racy of 8 automated estradiol assays with ID-GC-MS as the 
reference method.
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M a t e r ia ls  a n d  M e t h o d s
The following automated methods and instruments 
were evaluated: the Access analyzer (Beckman Coulter, 
Brea, CA), the ADVIA Centaur analyzer (Bayer Diagnos­
tics, Tarrytown, NY), the ARCHITECT i2000 analyzer 
using current reagents and reagents for a method that is in 
development (Abbott Diagnostics, Abbott Park, IL), the 
AutoDELFIA automatic immunoassay system (Wallac Oy, 
Turku, Finland), the Elecsys 2010 analyzer (Roche Diag­
nostics, Indianapolis, IN), the IMMULITE 2000 analyzer 
(Diagnostics Products, Los Angeles, CA), and the Vitros 
ECi analyzer (Ortho-Clinical Diagnostics, Raritan, NJ). All 
of these immunoassay methods use a competitive format. 
All methods use rabbit antiestradiol antibodies except for 
the Vitros ECi assay, which uses both rabbit and sheep 
antiestradiol antibodies. The ARCHITECT i2000 in devel­
opment assay requires 150 ^L o f sample compared with 
100 nL for the current assay and has a comparable resis­
tance to interference by hemolysis, icterus, and lipemia. 
The Elecsys 2010 assay adds mesterolone to release estra­
diol from the sample.
Assay imprecision was assessed by assaying aliquots of 
5 serum pools with estradiol concentrations of 18, 31, 93, 
387, and 846 pg/mL (66, 114, 341, 1,420, and 3,105 
pmol/L, respectively) in 6 replicates each on 2 different 
days for a total of 12 measurements. The estradiol concen­
tration of these samples was determined by ID-GC-MS as 
previously described.9 Functional sensitivity, defined as the 
estradiol concentration that would produce a coefficient of 
variation (CV) of 10%, was determined from a power curve 
fit o f the CV plotted against the estradiol concentration 
determined by ID-GC-MS.
A method comparison study between each of the 8 
estradiol assays and the ID-GC-MS reference method was 
performed using 61 samples with estradiol concentrations 
ranging from 0 to 1,101 pg/mL (0-4,041 pmol/L). EP Evalu­
ator Release 5 software (David G. Rhoads Associates, 
Kennett Square, PA) was used for simple precision calcula­
tions and Deming regression analysis. For Deming regres­
sion analysis, the same SD was used for each method.
R e s u l t s
A summary of data from the imprecision study is shown 
in ITable II. CVs ranged from 1.2% to 42.6% for estradiol 
concentrations from 18 to 846 pg/mL (66-3,105 pmol/L). At 
18 pg/mL (66 pmol/L), the range of CV observed for each 
method was broad, ranging from 6.9% on the Elecsys 2010 
to 42.6% on the ADVIA Centaur. At 93 pg/mL, CVs became 
more uniform and ranged from 2.5% on the ARCHITECT
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i2000 in development to 9.4% on the IMMULITE 2000. The 
functional sensitivities for a cutoff CV of 10% were deter­
mined from the data and are listed in ITable 21. The ARCHI­
TECT i2000 in development, Elecsys 2010, and Vitros ECi 
are capable of determining estradiol concentrations as low as 
18 pg/mL (66 pmol/L) while maintaining CVs of less than 
10%. The remaining instruments had functional sensitivities 
ranging from 35 to 80 pg/mL (128-294 pmol/L). It is note­
worthy that the mean estradiol concentrations obtained by 
some immunoassay methods for the sample with the lowest 
estradiol concentration were substantially higher than the ID- 
GC-MS reference method.
Comparison of results obtained for samples collected 
from individual subjects using the 8 automated estradiol 
immunoassays and the reference ID-GC-MS method by 
Deming regression analysis is shown IFigure II. There 
were varying degrees o f assay accuracy apparent, with 
slopes ranging from 0.87 to 1.20. The Access, ARCHI­
TECT i2000 in development, and IMMULITE 2000 assays 
had the best accuracy with slopes of 0.99, 0.98, and 1.03 
respectively. The AutoDELFIA and Elecsys 2010 assays 
showed the poorest accuracy with slopes of 0.87 and 1.20, 
respectively. Difference plots for the same data are shown 
IFigure 21. The dispersion o f data around the regression 
line, as reflected in the standard error of the estimate (S /3t) 
and the correlation coefficient (r) and represented graphi­
cally in the difference plot, showed that the ARCHITECT 
i2000 assay in development had the best agreement with 
the reference method with an Sy/x o f  23 pg/m L (84 
pmol/L), r =  0.997, followed by the Elecsys 2010 method 
with an Sy/x of 28 pg/mL (103 pmol/L) and r = 0.997. The 
ADVIA Centaur had the largest amount of dispersion with 
an Sy/x of 66 pg/mL (242 pmol/L) and r = 0.980.
D i s c u s s i o n
Our protocol for assessing imprecision was abbreviated 
owing to limited quantities of serum assayed by the ID-GC- 
MS reference method. Therefore, the tine overall impreci­
sion of the estradiol immunoassays during multiple days of 
analysis and multiple reagent lots is likely to be substantially 
higher than our data would indicate. Nevertheless, our results 
reflect the relative imprecision of each method.
O f the 8 estradiol immunoassays evaluated, the 
ARCHITECT i2000 assay in development, Elecsys 2010, 
and Vitros ECi methods were the most precise at low estra­
diol concentrations, being able to quantify estradiol concen­
trations as low as 18 pg/mL (66 pmol/L) while maintaining 
CVs of less than 10%. The Access, ARCHITECT i2000 
assay in development, and IMMULITE 2000 had the best 
average results compared with the reference method, with
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ITable II
Summary of Imprecision Data '
Method* Serum Pool
Estradiol Concentration (pg/mL) 
ID-GC-MS Method Mean Coefficient of Variation (% )
Access 1 18 38.7 14.7
2 31 52.5 8.0
3 93 98.2 9.3
4 387 422.0 3.3
5 846 824.9 3.9
ADVIA Centaur 1 18 40.5 42.6
2 31 57.4 19.4
3 93 106.2 6.5
4 387 443.7 6.8
5 846 1,065.5 7.6
ARCHITECT i2000 1 18 58.6 12.0
2 31 60.3 15.7
3 93 119.8 4.8
4 387 458.3 2.0
5 846 >1,000 Not determined
ARCHITECT i2000 in development 1 18 25.1 9.9
2 31 30.2 5.1
3 93 75.9 2.5
4 387 256.4 1.2
5 846 893.3 2.5
AutoDELFIA 1 18 22.9 31.4
2 31 32.7 20.3
3 93 90.9 5.8
4 387 361.2 3.7
5 846 718.9 4.3
Elecsys 2010 1 18 28.1 6.9
2 31 35.5 8.9
3 93 91.6 4.9
4 387 520.0 3.6
5 846 1,023.1 3.6
IMMULITE 2000 1 18 28.4 14.7
2 31 20.9 21.0
3 93 67.9 9.4
4 387 368.6 4.7
5 846 901.6 4.4
Vitros ECi 1 18 34.9 8.9
2 31 38.1 6.6
3 93 73.7 6.1
4 387 338.0 2.5
5 846 673.3 3.1
ID-GC-MS, isotope dilution-gas chromatography-mass spectrometry,
* Values are given in conventional units; for conversion to Systeme International units (pmol/L), multiply by 3.67, 
t For proprietary information, see the text.
ITable 21
Estimated Functional Sensitivity '
slopes very close to 1.0. The remainder of the instruments 
showed varying degrees of bias and possibly could benefit 
from improved calibration. This is especially true for the 
Elecsys 2010, which demonstrated excellent precision but 
had a positive proportional bias.
Ovarian stimulation protocols require serial monitoring 
o f  estradiol levels to direct dosage adjustments o f 
gonadotropins for optimization o f follicular growth and 
prevention of ovarian overstimulation.10-11 Most of these 
decision points are between estradiol concentrations of 200 
and 2,000 pg/mL (734-7,340 pmol/L),10 and all 8 instru­
ments have adequate precision within this range with CVs of 
less than 10%. Before initiating an ovarian stimulation 
protocol, differentiating populations with poor stimulation
Assay Functional Sensitivity (pg/mL)
Access 37
ADVIA Centaur 116 (61)f
ARCHITECT i2000 35





* The functional sensitivity was defined as the estradiol concentration that would 
produce a coefficient of variation (CV) of 10%, It was estimated from a power 
curve fit of the data in Table 1 as shown in Figure 1, For proprietary information, 
see the text.
t Inspection of the power curves in Figure 1 revealed that the concentration of 
estradiol corresponding to a CV of 10% was overestimated for the ADVIA Centaur 
and AutoDELFIA methods. The imprecision data for the 18,31, and 93 pg/mL 
samples were refitted with a power curve, and the result shown in parentheses 
provides a better estimate of the true functional sensitivity of these assays.
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IFigure II Comparison of estradiol immunoassay and isotope dilution-gas chromatography-mass spectrometry (ID-GC-MS) 
results using Deming regression. The solid lines are from Deming regression analysis, and the dashed lines are x = y. Data are 
given for the assay compared with the ID-GC-MS reference method. A, Access: slope, 0.99; intercept, 21 pg/mL; standard 
error of the estimate (Sy/X), 38 pg/mL; r = 0.992. B, ADVIA Centaur: slope, 1.10; intercept, 9 pg/mL; S /x, 66 pg/mL; r= 0.980.
C, ARCHITECT i2000: slope, 1.12; intercept, 41 pg/mL; Sy/X, 40 pg/mL; r = 0.993. D, ARCHITECT i2000 in development: slope, 
0.98; intercept, 1 pg/mL; Sy/X, 23 pg/mL; r = 0.997. E, AutoDELFIA: slope, 0.87; intercept, 17 pg/mL; Sy/X, 32 pg/mL; r = 0.993. 
F, Elecsys 2010: slope, 1.20; intercept, -1 pg/mL; Sy/X, 28 pg/mL; r = 0.997 G, IMMULITE 2000: slope, 1.03; intercept,
-7 pg/mL; Sy/X, 36 pg/mL; r = 0.993. H, Vitros ECi: slope, 0.92; intercept, -9 pg/mL; Sy/X, 32 pg/mL; r = 0.993. GC-MS, gas 
chromatography-mass spectrometry Intercept and Sy/X values are given in conventional units; for conversion to Systeme 
International units (pmol/L), multiply by 3.67 For proprietary information, see the text.
characteristics from those with good stimulation characteris­
tics is a prognostic necessity to select the appropriate stimu­
lation protocol. This can be done by measuring basal levels 
o f estradiol and follicle stimulating hormone on day 3 o f the 
menstrual cycle, and the determination point is an estradiol 
concentration o f 60 pg/mL (220 pmol/L).12 All o f the assays 
except the IMMULITE 2000 demonstrated what we consider 
to be adequate precision at low estradiol concentrations for 
this task (CV <10%).
While the Access, ARCHITECT i2000 assay in devel­
opment, and IMMULITE 2000 assays demonstrated good 
concordance with the reference method, additional calibra­
tion standardization o f the ADVIA Centaur, AutoDELFIA, 
Elecsys 2010, and Vitros ECi assays might improve their 
accuracy and could lead to better harmonization of estradiol 
results. Additional studies to examine interfering substances,
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particularly endogenous and exogenous estrogens, need to be 
performed because the presence o f some potential cross­
reacting substances could contribute to the bias and scatter 
observed for some o f the methods.
The clinical applications o f estradiol assays can be 
diverse. This study shows that the ARCHITECT i2000 assay 
in development, Elecsys 2010, and Vitros ECi assays have 
adequate low-end precision for the measurement of estradiol 
levels in men and postmenopausal women, but the accuracy 
o f the Elecsys 2010 method needs some improvement. The 
rapid analysis time and low technical demands o f automated 
immunoassays have made these instruments popular' in the 
field of assisted reproduction. Within the range o f estradiol 
concentrations typically encountered in this application, the 
Access, ARCHITECT i2000 in development, and Vitros ECi 
assays seem to have adequate precision and accuracy. The
Am J  Clin Pathol 2004; 122:332-337 3  3 5
DOI: 10 1309/BN2R4HT4GM0AGPBY
























600 900 1,200 §300 
GC-MS (pg/mL)
300 600 900 1,200 
GC-MS (pg/mL)



































300 600 900 1,200 
GC-MS (pg/mL)
IFigure 21 Comparison of estradiol immunoassays with isotope dilution-gas chromatography-mass spectrometry by difference 
plots. The solid lines are the ± 2 SD limits of agreement, and the dashed lines are the mean bias. All values are given in 
conventional units (pg/mL); for conversion to Systeme International units (pmol/L), multiply by 3.67 A, Access: mean bias, +20; 
limits of agreement, -55 and +95. B, ADVIA Centaur: mean bias, +34; limits of agreement, -104 and +172. C, ARCHITECT 
i2000: mean bias, +70; limits of agreement, -32 and +173. D, ARCHITECT i2000 in development: mean bias, -5; limits of 
agreement, -54 and +44. E, AutoDELFIA: mean bias, -17; limits of agreement, -122 and +89. F, Elecsys 2010: mean bias, 48; 
limits of agreement, -79 and +176. G, IMMULITE 2000: mean bias, 0; limits of agreement, -72 and +72. H, Vitros ECi: mean 
bias, -29; limits of agreement, -113 and +54. GC-MS, gas chromatography-mass spectrometry. For proprietary information, 
see the text.
changes made to the reagents for the ARCHITECT i2000 in 
development have resulted in an improvement in assay 
performance compared with the current ARCHITECT i2000 
reagents. The IMMULITE 2000, while accurate, lacked 
adequate precision at low estradiol concentrations for this 
application, and, conversely, the Elecsys 2010, while precise, 
lacked the requisite accuracy for this application.
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